Johannes W. J. Bijlsma mainly focuses on Internal medicine, Rheumatoid arthritis, Physical therapy, Cartilage and Osteoarthritis. His research ties Endocrinology and Internal medicine together. His Rheumatoid arthritis study incorporates themes from Placebo, Methotrexate, Surgery and Arthritis.
His Physical therapy research integrates issues from Alternative medicine, Randomized controlled trial, Psychological intervention and MEDLINE. He has included themes like Glycation, Immunology and Pathology in his Cartilage study. The Osteoarthritis study combines topics in areas such as Arthroplasty, Muscle weakness, Physical medicine and rehabilitation and Knee Joint.
His main research concerns Internal medicine, Rheumatoid arthritis, Physical therapy, Rheumatology and Immunology. Johannes W. J. Bijlsma interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine. His Rheumatoid arthritis study combines topics from a wide range of disciplines, such as Placebo, Randomized controlled trial, Surgery and Adverse effect.
The concepts of his Adverse effect study are interwoven with issues in Intensive care medicine and Glucocorticoid. His study focuses on the intersection of Physical therapy and fields such as Osteoarthritis with connections in the field of Cartilage and Physical medicine and rehabilitation. His Rheumatology study combines topics in areas such as Rheumatism and Family medicine.
Johannes W. J. Bijlsma focuses on Internal medicine, Rheumatoid arthritis, Rheumatology, Methotrexate and Tocilizumab. His work carried out in the field of Internal medicine brings together such families of science as Placebo, Physical therapy and Oncology. His study in Physical therapy is interdisciplinary in nature, drawing from both Osteoarthritis, WOMAC and Medical education.
His Rheumatoid arthritis research entails a greater understanding of Immunology. His Rheumatology research is multidisciplinary, incorporating elements of MEDLINE, Family medicine, Rheumatism, Disease and Hazard ratio. His work deals with themes such as Radiography, Randomized controlled trial, Treat to target, Meta-analysis and Joint damage, which intersect with Tocilizumab.
His primary areas of investigation include Internal medicine, Rheumatoid arthritis, Rheumatology, Physical therapy and Methotrexate. In Internal medicine, Johannes W. J. Bijlsma works on issues like Oncology, which are connected to Toxicity, Pathology and Observer variation. His Rheumatoid arthritis study combines topics from a wide range of disciplines, such as Adverse effect and Glucocorticoid.
His work carried out in the field of Rheumatology brings together such families of science as Systematic review, MEDLINE and Surgery. Physical therapy is closely attributed to Osteoarthritis in his study. His Methotrexate study combines topics in areas such as Placebo and Prednisone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch.
Annals of the Rheumatic Diseases (2014)
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
Linda Fernandes;Kåre B Hagen;Johannes W J Bijlsma;Oyvor Andreassen.
Annals of the Rheumatic Diseases (2013)
Effect of collagen turnover on the accumulation of advanced glycation end products.
Nicole Verzijl;Jeroen DeGroot;Suzanne R. Thorpe;Ruud A. Bank.
Journal of Biological Chemistry (2000)
Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases
Andrea W. M. Evers;Floris W. Kraaimaat;Wim van Lankveld;Peter J. H. Jongen.
Journal of Consulting and Clinical Psychology (2001)
Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: A systematic review of randomized clinical trials
Margriet E. Van Baar;Willem J. J. Assendelft;Joost Dekker;Rob A. B. Oostendorp.
Arthritis & Rheumatism (1999)
Low-Dose Prednisone Therapy for Patients with Early Active Rheumatoid Arthritis: Clinical Efficacy, Disease-Modifying Properties, and Side Effects: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Amalia A van Everdingen;Johannes W G Jacobs;Dirk R Siewertsz Van Reesema;Johannes W J Bijlsma.
Annals of Internal Medicine (2002)
Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: A possible mechanism through which age is a risk factor for osteoarthritis
Nicole Verzijl;Jeroen DeGroot;Chaya Ben Zaken;Orit Braun-Benjamin.
Arthritis & Rheumatism (2002)
Effects of glucocorticoids on radiological progression in rheumatoid arthritis.
John R Kirwan;Johannes Wj Bijlsma;Maarten Boers;Beverley Shea.
Cochrane Database of Systematic Reviews (2007)
Population-based assessment of adverse events associated with long-term glucocorticoid use.
Jeffrey R. Curtis;Andrew O. Westfall;Jeroan J. Allison;Johannes W. Bijlsma.
Arthritis & Rheumatism (2006)
Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Nicole Verzijl;Jeroen Degroot;Esther Oldehinkel;Ruud A. Bank.
Biochemical Journal (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: